NASDAQ: BTAI | --- | --- | --- | --- | --- | |----------------------------------------------|-------|-------|-------|-------| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Next Wave of Medicines Utilizing AI May 2020 | | | | | | | | | | | | | | | | | | | | | | | Forward-Looking Statements This presentation includes "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements in this presentation include, but are not limit ...

BioXcel Therapeutics, Inc. (NASDAQ:BTAI) Q1 2020 Results Conference Call May 12, 2020 8:30 AM ET Company Participants Vimal Mehta - Founder and CEO Richard Steinhart - VP and CFO Frank Yocca - SVP and Chief Scientific Officer Vincent O'Neill - SVP and Chief Medical Officer Rob Risinger - VP, Clinical Development Conference Call Participants Scott Puckhaber - Bank of America Robyn Karnauskas - SunTrust Robinson Humphrey Guyn Kim - BMO Capital Markets Sumant Kulkarni - Canaccord Samir Devani - RX Securities O ...

NASDAQ: BTAI | --- | --- | --- | --- | --- | --- | |------------|-------------------------------------|-------|-------|-------|-------| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | March 2020 | Next Wave of Medicines Utilizing AI | | | | | | | | | | | | | | | | | | | | | | | | | | Forward-Looking Statements This presentation includes "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements in this presentation include, b ...

BioXcel Therapeutics, Inc. (NASDAQ:BTAI) Q4 2019 Earnings Conference Call March 9, 2020 8:30 AM ET Company Participants Vimal Mehta - Founder and CEO Richard Steinhart - VP and CFO Frank Yocca - SVP and Chief Scientific Officer Vincent O'Neill - SVP and Chief Medical Officer Rob Risinger - VP, Clinical Development Conference Call Participants Robyn Karnauskas - SunTrust Robinson Humphrey Sumant Kulkarni - Canaccord Genuity Do Kim - BMO Capital Markets Raghuram Selvaraju - H.C. Wainwright Operator Good morni ...

bioxcel therapeutics (NASDAQ: BTAI) | --- | --- | --- | |---------------------------------------------------------------------------------|-------|-------| | | | | | | | | | Next Wave of Medicines | | | | | | | | December 2019 BioXcel Therapeutics, 555 Long Wharf Drive, New Haven, CT 06511 1 | | | Forward-Looking Statements This presentation includes "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements in this presentation includ ...

BioXcel Therapeutics, Inc. (NASDAQ:BTAI) Q3 2019 Earnings Conference Call November 14, 2019 8:30 AM ET Company Participants Vimal Mehta - Founder and Chief Executive Officer Richard Steinhart - Vice President and Chief Financial Officer Frank Yocca - Senior Vice President and Chief Scientific Officer Vincent O'Neill - Senior Vice President and Chief Medical Officer Conference Call Participants Do Kim - BMO Capital Markets Minh Vong - SunTrust Robinson Humphrey Sumant Kulkarni - Canaccord Genuity Corp. Edwar ...

bioxcel therapeutics (NASDAQ: BTAI) | --- | --- | --- | |------------------------|-------|-------| | | | | | | | | | Next Wave of Medicines | | | | | | | | September 2019 | | | Forward-Looking Statements This presentation includes "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements in this presentation include, but are not limited to, statements that relate to the advancement and development of BXCL501 and BXCL701, anticipated m ...

BioXcel Therapeutics, Inc. (NASDAQ:BTAI) Q2 2019 Results Conference Call August 6, 2019 8:30 AM ET Company Participants Vimal Mehta - CEO Richard Steinhart - CFO Frank Yocca - Chief Scientific Officer Vincent O'Neill - SVP & Chief Medical Officer Conference Call Participants Andrea Brettler - UBS Edward White - H.C. Wainwright Operator Good morning, and welcome to BioXcel Therapeutics Second Quarter 2019 Earnings Conference Call and Audio Webcast. Before we start, I would like to inform you that this confer ...